Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Alberta
$27,000.00
Investigating the role of hepatocyte membrane type 1 matrix metalloproteinase in regulating systemic glucose-lipid metabolism in response to high fat diet-induced metabolic dysfunction
FY 2025-26
Summary
Currently, about 6 million Canadians are living with type 2 diabetes (T2D), a chronic condition characterized by high fasting blood sugar (hyperglycemia) and reduced sensitivity to insulin, a pancreatic hormone that helps control blood sugar levels. When insulin is first released from the pancreas, it travels to the liver, which acts as a central metabolic hub for processing and storing nutrients, sending signals that fine-tune whole-body sugar metabolism. However, in T2D, the body becomes insulin resistant, resulting in elevated blood sugar. Our research group identified that the liver protein membrane type 1 matrix metalloproteinase (MT1-MMP) may help control blood sugar. Recent advances suggest MT1-MMP acts like molecular scissors, trimming key cell surface proteins for nutrient sensing and signaling. We found that mice lacking functional MT1-MMP in their liver had higher fasting blood sugar but lower insulin and were less responsive to insulin compared to their wild-type littermates. Our preliminary results therefore suggest that 1) liver MT1-MMP reshapes whole-body sugar metabolism and 2) loss of MT1-MMP in the liver decreases the body’s response to insulin. We hypothesize that liver MT1-MMP improves whole body sugar metabolism and is protective against hyperglycemia driven T2D under dietary stress. Using mouse models, I will investigate how 1) the loss of MT1-MMP impacts the sex-specific progression of T2D under a high fat diet and 2) challenge mice with insulin and observe changes to insulin-stimulated sugar uptake and metabolism. Understanding how liver MT1-MMP regulates whole body sugar metabolism under dietary stress will address a critical gap in the early development of T2D, informing new therapeutic strategies that target insulin resistance and diabetes.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572904
Name
Patel Raj
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of hepatocyte membrane type 1 matrix metalloproteinase in regulating systemic glucose-lipid metabolism in response to high fat diet-induced metabolic dysfunction
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Dietary Stress; Glucose Metabolism; Insulin Resistance; Lipid Metabolism; Liver; Matrix Metalloproteinase 14; Metabolic Dysfunction; Obesity; Sex Specific Differences; Type 2 Diabetes
Abstract
Currently, about 6 million Canadians are living with type 2 diabetes (T2D), a chronic condition characterized by high fasting blood sugar (hyperglycemia) and reduced sensitivity to insulin, a pancreatic hormone that helps control blood sugar levels. When insulin is first released from the pancreas, it travels to the liver, which acts as a central metabolic hub for processing and storing nutrients, sending signals that fine-tune whole-body sugar metabolism. However, in T2D, the body becomes insulin resistant, resulting in elevated blood sugar. Our research group identified that the liver protein membrane type 1 matrix metalloproteinase (MT1-MMP) may help control blood sugar. Recent advances suggest MT1-MMP acts like molecular scissors, trimming key cell surface proteins for nutrient sensing and signaling. We found that mice lacking functional MT1-MMP in their liver had higher fasting blood sugar but lower insulin and were less responsive to insulin compared to their wild-type littermates. Our preliminary results therefore suggest that 1) liver MT1-MMP reshapes whole-body sugar metabolism and 2) loss of MT1-MMP in the liver decreases the body’s response to insulin. We hypothesize that liver MT1-MMP improves whole body sugar metabolism and is protective against hyperglycemia driven T2D under dietary stress. Using mouse models, I will investigate how 1) the loss of MT1-MMP impacts the sex-specific progression of T2D under a high fat diet and 2) challenge mice with insulin and observe changes to insulin-stimulated sugar uptake and metabolism. Understanding how liver MT1-MMP regulates whole body sugar metabolism under dietary stress will address a critical gap in the early development of T2D, informing new therapeutic strategies that target insulin resistance and diabetes.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Patel, Raj
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~